By adminPosted on April 3, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in patients with untreated NSCLC. BeiGene Scraps TIGIT Candidate After Underwhelming Lung Cancer Data Views: 0 Post navigation Senate unveils plan to fast-track tax cuts, debt ceiling hikeSecretive Biotech Xaira Hires Top AI Academic To Take His Work to ‘the Next Level’
